Prime Sterile Services, Southampton

These two advanced healthcare facilities at Southampton's Adanac Health and Innovation Campus marks a significant step forward in improving regional healthcare services.

Our role with Prime plc involved constructing a 6600m2 multi-use facility to house a highly specialised aseptic pharmacy and Sterile Services Department. The facility will also manufacture sterile medicines for University Hospital Southampton and other NHS providers across the region. A key highlight of the pharmacy’s capabilities is its upcoming production of TBN, a vital drug for premature babies, which will be produced exclusively at this facility for the entire Southern UK region.

The two state-of-the-art specialist facilities were developed by Prime plc in partnership with University Hospital Southampton NHS Foundation Trust (UHS).

This project highlights the success and value of public-private partnerships in addressing the growing demands of healthcare infrastructure. The facility will support UHS, one of the UK’s largest and busiest teaching hospitals, by alleviating space constraints and bolstering the hospital’s ability to provide cutting-edge care to patients.

The Aseptic Pharmacy will act as an MHRA-licensed pharmacy, with drugs and medicines manufactured for University Hospital Southampton and other NHS providers in the region. Meanwhile, the SSD will sterilise surgical tools and equipment for use by University Hospital Southampton.

Highest specification

To ensure the highest standards of cleanliness and safety, we worked with Enblock Ltd, a specialist contractor in delivering design and build Cleanrooms. This collaboration reflects the importance of attention to detail and the operational excellence needed to support this critical healthcare service.

Highest sustainable credentials

The new development is a testament to sustainability, achieving BREEAM Excellent certification and featuring numerous photovoltaic panels to generate clean energy.

What people said

Phil Holland, Chief Investment Officer at Prime:

“These new facilities are a critical step in enhancing Southampton’s medical capabilities and preserving vital clinical space for UHS. They represent a strong collaboration between public and private sectors, with the shared goal of ensuring the region remains at the forefront of healthcare excellence and sustainability.”

Sam Morton, Managing Director at IHSS:

“We are incredibly proud of the collaboration between IHSS, our partners, and the dedicated teams working on this state-of-the-art supercentre. We look forward to the positive impact this facility will have on providing world-class decontamination services in the region."

Richard Poulter, Managing Director at Willmott Dixon in the South:

“We are proud to have played a key role in delivering these state-of-the-art healthcare facilities at Adanac Health and Innovation Campus. This project showcases the power of collaboration in addressing the evolving needs of the NHS and the wider healthcare sector. By combining innovative design, specialist expertise, and a strong sustainability focus, we have created a facility that will make a lasting impact on patient care and medical services across the region.”

Exciting future

The facilities mark a major milestone in the ongoing development work at the University Hospital Southampton.

Combined with the Trust's wider offerings, the new building will contribute towards the long-term goal of deepening the reputation of Southampton as a centre for medical excellence, preserving clinical space and enriching the local economy.